These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

404 related articles for article (PubMed ID: 33810024)

  • 1. Mitochondria and Pharmacologic Cardiac Conditioning-At the Heart of Ischemic Injury.
    Lotz C; Herrmann J; Notz Q; Meybohm P; Kehl F
    Int J Mol Sci; 2021 Mar; 22(6):. PubMed ID: 33810024
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Mitochondria "THE" target of myocardial conditioning.
    Boengler K; Lochnit G; Schulz R
    Am J Physiol Heart Circ Physiol; 2018 Nov; 315(5):H1215-H1231. PubMed ID: 30004243
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Inhibition of dynamin-related protein 1 protects against myocardial ischemia-reperfusion injury in diabetic mice.
    Ding M; Dong Q; Liu Z; Liu Z; Qu Y; Li X; Huo C; Jia X; Fu F; Wang X
    Cardiovasc Diabetol; 2017 Feb; 16(1):19. PubMed ID: 28173848
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Mitochondrial LonP1 protects cardiomyocytes from ischemia/reperfusion injury in vivo.
    Venkatesh S; Li M; Saito T; Tong M; Rashed E; Mareedu S; Zhai P; Bárcena C; López-Otín C; Yehia G; Sadoshima J; Suzuki CK
    J Mol Cell Cardiol; 2019 Mar; 128():38-50. PubMed ID: 30625302
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Mitochondria in postconditioning.
    Boengler K; Heusch G; Schulz R
    Antioxid Redox Signal; 2011 Mar; 14(5):863-80. PubMed ID: 20578961
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Ischemia reperfusion injury, ischemic conditioning and diabetes mellitus.
    Lejay A; Fang F; John R; Van JA; Barr M; Thaveau F; Chakfe N; Geny B; Scholey JW
    J Mol Cell Cardiol; 2016 Feb; 91():11-22. PubMed ID: 26718721
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Chronic Tempol treatment restores pharmacological preconditioning in the senescent rat heart.
    Zhu J; Rebecchi MJ; Wang Q; Glass PS; Brink PR; Liu L
    Am J Physiol Heart Circ Physiol; 2013 Mar; 304(5):H649-59. PubMed ID: 23275621
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Mitochondrial bioenergetics and cardiolipin alterations in myocardial ischemia-reperfusion injury: implications for pharmacological cardioprotection.
    Paradies G; Paradies V; Ruggiero FM; Petrosillo G
    Am J Physiol Heart Circ Physiol; 2018 Nov; 315(5):H1341-H1352. PubMed ID: 30095969
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Tongmai formula improves cardiac function via regulating mitochondrial quality control in the myocardium with ischemia/reperfusion injury.
    Zhao Y; Guo R; Li L; Li S; Fan G; Zhao X; Wang Y
    Biomed Pharmacother; 2020 Dec; 132():110897. PubMed ID: 33113431
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Molecular basis of cardioprotection: signal transduction in ischemic pre-, post-, and remote conditioning.
    Heusch G
    Circ Res; 2015 Feb; 116(4):674-99. PubMed ID: 25677517
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Pharmacological pre- and post- conditioning agents: reperfusion-injury of the heart revisited.
    Andreadou I; Iliodromitis EK; Koufaki M; Kremastinos DT
    Mini Rev Med Chem; 2008 Aug; 8(9):952-9. PubMed ID: 18691153
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Nutritional preconditioning induced by astragaloside Ⅳ on isolated hearts and cardiomyocytes against myocardial ischemia injury via improving Bcl-2-mediated mitochondrial function.
    Luo Y; Wan Q; Xu M; Zhou Q; Chen X; Yin D; He H; He M
    Chem Biol Interact; 2019 Aug; 309():108723. PubMed ID: 31228469
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Mitochondrial permeability transition in cardiac cell injury and death.
    Honda HM; Ping P
    Cardiovasc Drugs Ther; 2006 Dec; 20(6):425-32. PubMed ID: 17171295
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Anesthetic cardioprotection in relation to mitochondria: basic science.
    Mio Y; Uezono S; Kitahata H
    Curr Pharm Des; 2014; 20(36):5673-80. PubMed ID: 24502577
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Keeping the engine primed: HIF factors as key regulators of cardiac metabolism and angiogenesis during ischemia.
    Shohet RV; Garcia JA
    J Mol Med (Berl); 2007 Dec; 85(12):1309-15. PubMed ID: 18026917
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Penehyclidine hydrochloride preconditioning provides cardiac protection in a rat model of myocardial ischemia/reperfusion injury via the mechanism of mitochondrial dynamics mechanism.
    Yang Y; Zhao L; Ma J
    Eur J Pharmacol; 2017 Oct; 813():130-139. PubMed ID: 28755984
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Pathophysiology of myocardial reperfusion injury: preconditioning, postconditioning, and translational aspects of protective measures.
    Sanada S; Komuro I; Kitakaze M
    Am J Physiol Heart Circ Physiol; 2011 Nov; 301(5):H1723-41. PubMed ID: 21856909
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Myocardial triggers involved in activation of remote ischaemic preconditioning.
    Donato M; Goyeneche MA; Garces M; Marchini T; Pérez V; Del Mauro J; Höcht C; Rodríguez M; Evelson P; Gelpi RJ
    Exp Physiol; 2016 Jun; 101(6):708-16. PubMed ID: 27028009
    [TBL] [Abstract][Full Text] [Related]  

  • 19. High-dose Humanin analogue applied during ischemia exerts cardioprotection against ischemia/reperfusion injury by reducing mitochondrial dysfunction.
    Thummasorn S; Shinlapawittayatorn K; Chattipakorn SC; Chattipakorn N
    Cardiovasc Ther; 2017 Oct; 35(5):. PubMed ID: 28726291
    [TBL] [Abstract][Full Text] [Related]  

  • 20. What is Wrong With Cardiac Conditioning? We May be Shooting at Moving Targets.
    Iliodromitis EK; Cohen MV; Dagres N; Andreadou I; Kremastinos DT; Downey JM
    J Cardiovasc Pharmacol Ther; 2015 Jul; 20(4):357-69. PubMed ID: 25627214
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 21.